{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:10:19Z","timestamp":1781557819522,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.leukres.2022.106952","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T11:28:22Z","timestamp":1663327702000},"page":"106952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["5\u2032 Rapid amplification of cDNA ends (5\u2032RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"123","author":[{"given":"Xuan","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ruminy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Bohers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinciane","family":"Rainville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Viennot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Julien","family":"Viailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Etancelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Tilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorina","family":"Mihailescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Bouclet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Lepr\u00eatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Jardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.leukres.2022.106952_bib1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2007.06847.x","article-title":"Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis","volume":"139","author":"Linet","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib2","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.leukres.2022.106952_bib3","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2022.106952_bib4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2022.106952_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ajh.24660","article-title":"Chronic lymphocytic leukemia: a prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI","volume":"92","author":"Delgado","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2022.106952_bib6","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood.V97.6.1892","article-title":"CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia","volume":"97","author":"Thunberg","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood.V96.1.377","article-title":"Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia","volume":"96","author":"Maloum","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2022.106952_bib8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184","article-title":"Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors","volume":"100","author":"Oscier","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2022.106952_bib9","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia","volume":"100","author":"Kr\u00f6ber","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2022.106952_bib10","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/bjh.13940","article-title":"The outcome of chronic lymphocytic leukaemia patients with 97\u00a0% IGHV gene identity to germline is distinct from cases with <97\u00a0% identity and similar to those with 98\u00a0% identity","volume":"173","author":"Davis","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bjh.15015","article-title":"The absolute percent deviation of IGHV mutation rather than a 98\u00a0% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab","volume":"180","author":"Gocke","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.leukres.2022.106952_bib13","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1002\/ajh.25206","article-title":"Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: mutational load or mutational status? Analysis of 1003 cases","volume":"93","author":"Morabito","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2022.106952_bib14","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/leu.2017.125","article-title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations","volume":"31","author":"Rosenquist","year":"2017","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2022.106952_bib15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/leu.2011.49","article-title":"Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases","volume":"25","author":"Langerak","year":"2011","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.leukres.2022.106952_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.leukres.2022.106952_bib17","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","article-title":"Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia","volume":"104","author":"Tobin","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20\u00a0% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2022.106952_bib19","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2022.106952_bib20","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2005-04-1511","article-title":"Immunoglobulin light chain repertoire in chronic lymphocytic leukemia","volume":"106","author":"Stamatopoulos","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2022.106952_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJMoa1817073","article-title":"Ibrutinib-Rituximab or chemoimmunotherapy for chronic lymphocytic leukemia","volume":"381","author":"Shanafelt","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.leukres.2022.106952_bib22","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1073\/pnas.1913810117","article-title":"IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling","volume":"117","author":"Maity","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.leukres.2022.106952_bib23","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1158\/1078-0432.CCR-18-0133","article-title":"The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia: results of a multicenter study","volume":"24","author":"Stamatopoulos","year":"2018","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"issue":"21","key":"10.1016\/j.leukres.2022.106952_bib24","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood.2020008311","article-title":"IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics","volume":"137","author":"Nadeu","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2022.106952_bib25","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1038\/s41375-020-0923-9","article-title":"Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing","volume":"34","author":"Davi","year":"2020","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.leukres.2022.106952_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.it.2014.09.004","article-title":"Characterizing immune repertoires by high throughput sequencing: strategies and applications","volume":"35","author":"Calis","year":"2014","journal-title":"Trends Immunol."},{"issue":"25","key":"10.1016\/j.leukres.2022.106952_bib27","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2022.106952_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1145\/360825.360855","article-title":"Efficient string matching: an aid to bibliographic search","volume":"18","author":"Aho","year":"1975","journal-title":"Commun. ACM"},{"key":"10.1016\/j.leukres.2022.106952_bib29","doi-asserted-by":"crossref","unstructured":"IgBLAST: an immunoglobulin variable domain sequence analysis tool | Nucleic Acids Research | Oxford Academic. Accessed 20 June 2022. \u3008https:\/\/academic.oup.com\/nar\/article\/41\/W1\/W34\/1097536\u3009.","DOI":"10.1093\/nar\/gkt382"},{"key":"10.1016\/j.leukres.2022.106952_bib30","doi-asserted-by":"crossref","unstructured":"Lefranc M.P. , Giudicelli V. , Kaas Q. , et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 2005;33(Database issue):D593\u2013597. doi:10.1093\/nar\/gki065.","DOI":"10.1093\/nar\/gki065"},{"key":"10.1016\/j.leukres.2022.106952_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/1471-2334-14-531","article-title":"High prevalence of HIV infection and unprotected anal intercourse among older men who have sex with men in China: a systematic review and meta-analysis","volume":"14","author":"Li","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib32","doi-asserted-by":"crossref","DOI":"10.1530\/EC-21-0364","article-title":"Comparison of the clinical characteristics of primary thyroid lymphoma and diffuse sclerosing variant of papillary thyroid carcinoma","volume":"11","author":"Zheng","year":"2022","journal-title":"Endocr. Connect"},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib33","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2352-3026(17)30232-6","article-title":"Epidemiological patterns of leukaemia in 184 countries: a population-based study","volume":"5","author":"Miranda-Filho","year":"2018","journal-title":"Lancet Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2022.106952_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41416-019-0502-x","article-title":"The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia","volume":"121","author":"Visentin","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"10129","key":"10.1016\/j.leukres.2022.106952_bib35","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","article-title":"Chronic lymphocytic leukaemia","volume":"391","author":"Hallek","year":"2018","journal-title":"Lancet Lond. Engl."},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib36","first-page":"55","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies","volume":"14","author":"Koehrer","year":"2016","journal-title":"Clin. Adv. Hematol. Oncol. HO"},{"issue":"16","key":"10.1016\/j.leukres.2022.106952_bib37","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-14-0630","article-title":"Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution","volume":"74","author":"Vardi","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.leukres.2022.106952_bib38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/10428190701342034","article-title":"The immunoglobulin genes: structure and specificity in chronic lymphocytic leukemia","volume":"48","author":"Tobin","year":"2007","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/asheducation-2005.1.278","article-title":"CLL biology and prognosis","volume":"2005","author":"Dighiero","year":"2005","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.leukres.2022.106952_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2404457","article-title":"ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia","volume":"21","author":"Ghia","year":"2007","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2022.106952_bib41","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/leu.2016.307","article-title":"Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia","volume":"31","author":"Stamatopoulos","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2022.106952_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood-2008-07-166868","article-title":"Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia","volume":"113","author":"Hadzidimitriou","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2022.106952_bib43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2015-07-660969","article-title":"Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation","volume":"127","author":"Yeomans","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2022.106952_bib44","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/leu.2017.90","article-title":"NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components","volume":"31","author":"Pozzo","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2022.106952_bib45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ccell.2016.10.005","article-title":"Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia","volume":"30","author":"Wang","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2022.106952_bib46","doi-asserted-by":"crossref","first-page":"15746","DOI":"10.1038\/ncomms15746","article-title":"Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia","volume":"8","author":"Minici","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622001783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622001783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:19Z","timestamp":1758934999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622001783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":46,"alternative-id":["S0145212622001783"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106952","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5\u2032 Rapid amplification of cDNA ends (5\u2032RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106952"}}